No Data
Huayang Asia Vets (301502.SZ): Core product electronic injection pens have been maturely applied in areas such as growth hormone.
Gelonghui, November 20th, Huayang Asia Vets (301502.SZ) stated in recent investor relations activities that, first of all, the company's product functionality, user experience, etc. are basically no different from foreign-funded enterprises. Compared to foreign companies, the company has advantages in terms of development cost, development time cycle, and customer customization. Secondly, foreign-funded enterprises mainly use mechanical injection pens for mass market applications, while the company's core product electronic injection pen has been maturely applied in the field of growth hormone, providing customers with more choices.
Huayang asia vets (301502.SZ): Micro electric machine is currently mainly used in the refrigeration industry.
Grain rain on November 20th, Huayang asia vets (301502.SZ) stated in a recent investor relations event that Weite electric machines can be applied in various fields such as household appliances, autos, medical, new energy fund, mainly playing a role in control, drive and other functions. Due to the diverse applications of Weite electric machines, the overall market size is large. The company's Weite electric machines are currently mainly used in the refrigeration industry, with a high market position in the refrigeration segment, and the company is also expanding into more application fields.
Huayang Asia Vets (301502.SZ): Currently, there are no accessories and electric machine products related to humanoid siasun robot&automation applications.
On November 19, Gelonghui reported that Huayang asia vets (301502.SZ) stated on the investor interaction platform that the company currently has no accessories or electric machine products related to humanoid siasun robot&automation applications.
Huayang Intelligence: Report for the third quarter of 2024
Huayang Asia Vets (301502.SZ) released its performance for the first three quarters, with a net income of 25.1954 million yuan, a decrease of 47.6%.
Huayang Asia Vets (301502.SZ) released the third quarter report for 2024, with the company's revenue in the first three quarters at 3...
Huayang Asia Vets (301502.SZ): net income in the third quarter was 4.7593 million yuan, a year-on-year decrease of 66.14%.
Gelonghui October 22nd | Huayang Asia Vets (301502.SZ) announced the third quarter report for 2024, with revenue for the period at 94.09 million yuan, a decrease of 4.93% year-on-year; net income attributable to shareholders of the listed company at 4.7593 million yuan, a decrease of 66.14% year-on-year; net income attributable to shareholders of the listed company excluding non-recurring gains and losses at 2.9723 million yuan, a decrease of 78.40% year-on-year; basic earnings per share of 0.0767 yuan.
No Data
No Data